Dallah shareholders approve 2025 results and large transactions

Shareholders of Dallah Healthcare Services Company approved the 2025 financial statements and the Board of Directors' report, as well as transactions exceeding 540 million riyals, including an agreement to sell shares of the company valued at approximately 498 million riyals. They also approved the appointment of KPMG to audit the upcoming financial statements and authorized the Board of Directors to distribute semi-annual or quarterly dividends in 2027. The voting also covered the related-party transaction regulations and previous contracts after review in accordance with governance standards.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل